百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02315 百奥赛图-B

未开盘 01-09 16:08:33

35.900

+0.940

+2.69%

最高36.660	最低34.200	成交量181.89万
今开35.380	昨收34.960	日振幅7.04%
总市值160.47亿	流通市值39.85亿	总股本4.47亿
成交额6,488万	换手率1.64%	流通股本1.11亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02315","market":"HK","secType":"STK","nameCN":"百奥赛图-B","latestPrice":35.9,"timestamp":1767946113476,"preClose":34.96,"halted":0,"volume":1818946,"delay":0,"floatShares":111000000,"shares":447000000,"eps":0.084274,"marketStatus":"未开盘","change":0.94,"latestTime":"01-09 16:08:33","open":35.38,"high":36.66,"low":34.2,"amount":64878256,"amplitude":0.070366,"askPrice":36,"askSize":3500,"bidPrice":35.9,"bidSize":1000,"shortable":0,"etf":0,"ttmEps":0.324,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768181400000},"marketStatusCode":0,"adr":0,"listingDate":1661961600000,"exchange":"SEHK","adjPreClose":34.96,"openAndCloseTimeList":[[1767922200000,1767931200000],[1767934800000,1767945600000]],"volumeRatio":1.0430891771406723,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688796","market":"SH","secType":"STK","nameCN":"百奥赛图","latestPrice":59.79,"timestamp":1767942000000,"preClose":56.17,"halted":0,"volume":5036600,"delay":0,"premium":"-46.27"}},"requestUrl":"/m/hq/s/02315","defaultTab":"news","newsList":[{"id":"2602314642","title":"智通港股通占比异动统计|1月9日","url":"https://stock-news.laohu8.com/highlight/detail?id=2602314642","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2602314642?lang=zh_cn&edition=full","pubTime":"2026-01-09 08:36","pubTimestamp":1767918960,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，根据2025年12月31日披露数据，金风科技、纳芯微、狮腾控股港股通持股占比增加值最大，分别增加1.64%、1.48%、1.37%；浙江世宝、弘业期货、中远海能港股通持股占比减少值最大，分别减少-5.47%、-1.98%、-1.25%。在最近有统计数据的5个交易日内，南京熊猫电子股份、百奥赛图-B、狮腾控股港股通持股占比增加值最大，分别增加9.07%、6.23%、5.60%；浙江世宝、金科服务、中国中冶港股通持股占比减少值最大，分别减少-6.71%、-3.82%、-3.63%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1390693.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02172","01635","02648","01858","02562","01357","06099","06963","02192","02315","02628","00763","03908","01057","01772","06066","02431","09666","00187","03347","06680","01341","02208","02603","02432","06693","06865","02402","01375","00553","03958","01456","02676","01528","01709","06613","01918","02579","06166","00177","03759","06178","06869","01788","01618","03678","01138","00699","02865"],"gpt_icon":1},{"id":"2601536899","title":"67股发布2025年度业绩公告 报喜比例超七成","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536899","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601536899?lang=zh_cn&edition=full","pubTime":"2026-01-08 08:05","pubTimestamp":1767830700,"startTime":"0","endTime":"0","summary":"人民财讯1月8日电，1月7日晚间，16股发布2025年度业绩相关公告，其中川金诺、泉阳泉、北方导航、高能环境、康辰药业、中科蓝讯6股业绩预增，报喜比例为37.5%。截至目前，已有67股发布2025年度业绩相关公告，其中47股实现归母净利润同比增长或扭亏，报喜比例超过七成。从预告净利润同比增幅下限来看，中科蓝讯、百奥赛图、传化智联、康辰药业4股预告净利润同比增幅居前，均超过200%。分行业来看，上述预增或扭亏的47股中，属于基础化工行业的最多，共7股；其次是机械设备、电子、有色金属，分别有6股、5股、4股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108080613953c2ccf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260108080613953c2ccf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2601879446","title":"百奥赛图-B01月07日遭主力抛售354.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601879446","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601879446?lang=zh_cn&edition=full","pubTime":"2026-01-07 16:16","pubTimestamp":1767773763,"startTime":"0","endTime":"0","summary":"01月07日, 百奥赛图-B股价跌2.13%，报收35.82元，成交金额7011.7万元，换手率1.74%，振幅5.90%，量比0.75。百奥赛图-B今日主力资金净流出354.1万元，连续3日净流出，上一交易日主力净流出201.2万元。该股近5个交易日上涨4.01%，主力资金累计净流出697.6万元；近20日主力资金累计净流出876.0万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162320a4a6d84d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107162320a4a6d84d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2601760808","title":"港股创新药ETF基金涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601760808","media":"云掌财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601760808?lang=zh_cn&edition=full","pubTime":"2026-01-07 13:58","pubTimestamp":1767765495,"startTime":"0","endTime":"0","summary":"盘面上，港股创新药表现活跃，凯莱英飙涨7%，泰格医药、昭衍新药、康方生物涨超5%，和黄医药、翰森制药、恒瑞医药等个股涨超4%。截至10：34，热门ETF——港股创新药ETF基金上涨2.85%，冲击三连涨！数据显示，港股创新药ETF基金近60日“吸金”超1亿；最新基金规模达9.39亿元。港股创新药ETF基金跟踪中证港股通创新药指数，指数编制方式更科学合理，成分股涵盖如百济神州、信达生物和药明生物等领军企业。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107135820a4a649a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03692","01276","06127","06978","09926","BK1161","06821","01801","02315","BK1574","02269","00013","BK1191"],"gpt_icon":0},{"id":"2601696846","title":"百奥赛图-B盘中异动 早盘大幅下挫5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601696846","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601696846?lang=zh_cn&edition=full","pubTime":"2026-01-06 10:31","pubTimestamp":1767666716,"startTime":"0","endTime":"0","summary":"2026年01月06日早盘10时31分，百奥赛图-B股票出现异动，股价急速下挫5.08%。截至发稿，该股报33.980港元/股，成交量41万股，换手率0.37%，振幅8.16%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。百奥赛图-B股票所在的生物技术行业中，整体跌幅为0.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010610315697a115f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010610315697a115f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2601079117","title":"国联民生证券：首予百奥赛图(02315)“推荐”评级 基石业务稳增长 抗体平台高弹性","url":"https://stock-news.laohu8.com/highlight/detail?id=2601079117","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601079117?lang=zh_cn&edition=full","pubTime":"2026-01-05 10:31","pubTimestamp":1767580296,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国联民生证券发布研报称，首次覆盖，给予百奥赛图“推荐”评级，公司三大业务板块行业景气且收入高增，随着“千鼠万抗”计划实现阶段性成果，大规模研发投入进入尾声，募集资金有望大幅缓解财务费用。临床前产品及服务快速增长，抗体平台增长力强，海外加速渗透，25H1收入占比67.9%，全球top20合作客户数量及占比持续增加，客户优质。临床前CRO服务模式动物延伸而来，海外收入占比79%，投融资回暖趋势下高增确定性强。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","688796","01456","161027","601456"],"gpt_icon":0},{"id":"2601302724","title":"首波年报预披露公司来袭，谁在领跑盈利榜？","url":"https://stock-news.laohu8.com/highlight/detail?id=2601302724","media":"财经早餐","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601302724?lang=zh_cn&edition=full","pubTime":"2026-01-05 06:40","pubTimestamp":1767566408,"startTime":"0","endTime":"0","summary":"据公司公告，紫金矿业预计2025年度实现归属于上市公司股东的净利润约510亿元至520亿元，同比增加约59%至62%。主要原因在于报告期内主要矿产品产量同比增加。消费电子行业龙头立讯精密预计2025年归母净利润约为165.18亿元至171.86亿元，同比增长23.59%至28.59%。摩尔线程此前公告称，公司新产品尚未产生收入，产品实现销售尚需要经过产品认证、客户导入、量产供货等环节，均存在不确定性。公司未来的营业收入可能增长较慢或无法持续增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105065258a6f32fc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105065258a6f32fc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0326950275.SGD","LU1770034418.SGD","LU0417516902.SGD","LU0348827113.USD","LU0061477393.USD","LU0211977185.USD","LU0456854461.SGD","LU0871576103.HKD","LU1961090484.USD","LU0181495838.USD","LU0417516738.SGD","LU1224709979.USD","LU0329678337.USD","LU0345780281.USD","LU0149721374.USD","LU0164880469.USD","LU0737861699.HKD","LU0463099449.HKD","LU0886674414.USD","LU0979878070.USD","LU0828237510.HKD","LU0096374516.USD","LU1769817179.HKD","LU1048596156.SGD","LU0561508036.HKD","LU0531971595.HKD","LU2097828714.EUR","LU0266512473.USD","BK1592","LU0173614495.USD","HK0000306685.HKD","LU0345780521.USD","02315","LU0821914370.USD","LU2097828474.EUR","LU1481107354.HKD","SG9999002463.SGD","LU0329678170.USD","LU1188198961.HKD","LU1794554557.SGD","LU0287142896.SGD","02899","LU0266512127.USD","BK1505","LU2097828631.EUR","LU1831875114.USD","LU2399975544.HKD","HK0000306701.USD","LU1242518857.USD","LU0572944931.SGD","LU0588546209.SGD"],"gpt_icon":1},{"id":"2600043255","title":"2025年医药IPO市场回暖，20余家药企成功上市募资","url":"https://stock-news.laohu8.com/highlight/detail?id=2600043255","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600043255?lang=zh_cn&edition=full","pubTime":"2026-01-04 10:33","pubTimestamp":1767493992,"startTime":"0","endTime":"0","summary":"回顾刚刚过去的2025年，生物医药企业IPO活动回升，根据数据统计，2025年全年共有21家生物药企成功实现IPO。其中，药企上演赴港IPO狂欢，累计有18家公司在港交所上市，募资总额约235亿港元。港股生物医药板块于2025年迎来强力反弹，18家药企IPO。而2022年板块21家新上市企业全部破发；2023年IPO数量仅10家，募资总额约107亿港元。据悉，2025年恒瑞医药单笔募资113亿港元，创下板块IPO纪录。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104103529a6f041a5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260104103529a6f041a5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","01276","02315","LU2543165471.USD","09606","BK1574","HK0000252152.HKD","BK1161","HK0000252160.HKD","HK0000500386.USD","BK1515"],"gpt_icon":0},{"id":"2600499054","title":"百奥赛图-B盘中异动 股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2600499054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600499054?lang=zh_cn&edition=full","pubTime":"2026-01-02 09:37","pubTimestamp":1767317854,"startTime":"0","endTime":"0","summary":"2026年01月02日早盘09时37分，百奥赛图-B股票出现波动，股价大幅跳水5.10%。截至发稿，该股报33.500港元/股，成交量10000股，换手率0.01%，振幅4.25%。机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。百奥赛图-B股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，拨康视云-B、中国抗体-B、MIRXES-B涨幅较大，振幅较大的相关个股有北海康成-B、拨康视云-B、荃信生物-B，振幅分别为9.77%、6.92%、6.02%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102093734a6ea3e71&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260102093734a6ea3e71&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02315","BK1161"],"gpt_icon":0},{"id":"2595677036","title":"百奥赛图-B：魏义良辞任非执行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2595677036","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595677036?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:42","pubTimestamp":1767170520,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)公布，魏义良先生因其他工作安排已向公司提出辞呈，辞去其担任的非执行董事及董事会辖下审计委员会及战略发展委员会成员的职务，自 2025年12月31日起生效。百奥赛图-B(02315)公布，魏义良先生因其他工作安排已向公司提出辞呈，辞去其担任的非执行董事及董事会辖下审计委员会及战略发展委员会成员的职务，自 2025年12月31日起生效。追加内容本文作者可以追加内容哦 !","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231164420a6e4d21c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231164420a6e4d21c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2595770355","title":"百奥赛图-B12月31日获主力加仓980.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2595770355","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595770355?lang=zh_cn&edition=full","pubTime":"2025-12-31 16:15","pubTimestamp":1767168931,"startTime":"0","endTime":"0","summary":"12月31日, 百奥赛图-B股价涨2.68%，报收35.30元，成交金额1.0亿元，换手率2.55%，振幅13.79%，量比0.49。百奥赛图-B今日主力资金净流入980.8万元，连续3日净流入，上一交易日主力净流入27.3万元。该股近5个交易日上涨24.73%，主力资金累计净流入1996.4万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入827.4万元，其中净流入天数为5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161729a48db390&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231161729a48db390&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02315"],"gpt_icon":0},{"id":"2595744212","title":"百奥赛图-B盘中涨超5% 华福证券首予“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2595744212","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595744212?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:12","pubTimestamp":1767147120,"startTime":"0","endTime":"0","summary":"　　百奥赛图-B盘中涨超5%，截至发稿，股价上涨3.26%，现报35.50港元，成交额3126.55万港元。　　上交所与深交所近日公告，将百奥赛图调入港股通股票名单，自2025年12月24日起生效。　　华福证券此前研报指出，公司千鼠万抗开始兑现，抗体授权驱动业绩爆发。考虑公司业务的高成长性及高壁垒，临床前动物及药理药效评价基本盘稳固，抗体开发业务已逐步进入业绩兑现期，叠加潜在的新药管线具有潜力，首予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2025-12-31/doc-inhesahv5290752.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["02315","161027","688796"],"gpt_icon":0},{"id":"2595449417","title":"港股异动 | 百奥赛图-B(02315)再涨超5% 公司近期正式进入港股通名单 机构称千鼠万抗开始兑现","url":"https://stock-news.laohu8.com/highlight/detail?id=2595449417","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595449417?lang=zh_cn&edition=full","pubTime":"2025-12-31 10:05","pubTimestamp":1767146749,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B(02315)再涨超5%，截至发稿，涨4.94%，报36.08港元，成交额2758.41万港元。消息面上，上交所与深交所近日公告，将百奥赛图调入港股通股票名单，自2025年12月24日起生效。此举标志着公司构建“A+H”双资本市场平台后的又一重要里程碑，其港股通道自此向内地投资者全面敞开。华福证券此前研报指出，公司千鼠万抗开始兑现，抗体授权驱动业绩爆发。考虑公司业务的高成长性及高壁垒，临床前动物及药理药效评价基本盘稳固，抗体开发业务已逐步进入业绩兑现期，叠加潜在的新药管线具有潜力，首予“买入”评级。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387491.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688796","02315","BK1161"],"gpt_icon":0},{"id":"2595684745","title":"港股公司回A升温 “H转深A”有望增添新案例","url":"https://stock-news.laohu8.com/highlight/detail?id=2595684745","media":"人民财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595684745?lang=zh_cn&edition=full","pubTime":"2025-12-31 07:41","pubTimestamp":1767138115,"startTime":"0","endTime":"0","summary":"人民财讯12月31日电，12月29日，来自深圳的港股机器人企业越疆宣布，启动首次公开发行人民币普通股及于深交所上市计划。从已经登陆科创板的百奥赛图再到映恩生物、光大环境等港股企业启动A股上市计划，港股近期掀起一股积极“回A”的浪潮。值得关注的是，光大环境、越疆均为粤港澳大湾区企业，伴随着企业“回A”进程的推进，“H转深A”有望增添新的示范案例，进一步探索并完善该通道的具体实践路径。今年以来，A股公司赴港上市的趋势仍在延续，与此同时，港股企业回归A股市场也在不断升温。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231074158a48bf167&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251231074158a48bf167&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02432","02315","BK1183"],"gpt_icon":0},{"id":"2595270060","title":"港股异动 | 百奥赛图-B(02315)涨超6%再创新高 公司已正式进入港股通 机构指千鼠万抗前景广阔","url":"https://stock-news.laohu8.com/highlight/detail?id=2595270060","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595270060?lang=zh_cn&edition=full","pubTime":"2025-12-29 09:54","pubTimestamp":1766973261,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，百奥赛图-B早盘涨超6%，高见37.28港元，再创上市新高。消息面上，近日，上交所与深交所公告，将百奥赛图-调入港股通股票名单，自2025年12月24日起生效。银河证券发布研报称，百奥赛图公司以基因编辑技术为基石，随着公司主要投入的千鼠万抗计划进入兑现期，公司业绩有望带来大幅增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386349.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02315","BK0216","BK1161","688796"],"gpt_icon":0},{"id":"1172346911","title":"异动解读 | 百奥赛图-B(02315)盘中大涨5.19%，获纳入港股通名单提振股价","url":"https://stock-news.laohu8.com/highlight/detail?id=1172346911","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172346911?lang=zh_cn&edition=full","pubTime":"2025-12-29 09:36","pubTimestamp":1766972210,"startTime":"0","endTime":"0","summary":"百奥赛图-B(02315)今日盘中大涨5.19%，市场表现强劲。消息面上，公司H股正式被纳入港股通股票名单，自2025年12月24日起生效。这一举措标志着百奥赛图-B向内地投资者全面开放，预计将显著提升股票流动性和交易活跃度，并吸引更多南向资金流入，推动公司价值重估。此外，百奥赛图-B近期业绩表现亮眼，2025年前三季度营业收入同比增长59.5%，归母净利润成功扭亏为盈，展现出良好的盈利能力和成长潜力。公司独特的“双引擎”平台化商业模式和技术护城河也进一步增强了市场信心。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"1421e84be9d1e8ccf1d8f45413971ecf","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02315"],"gpt_icon":0},{"id":"2595277564","title":"百奥赛图-B(02315)获纳入港股通名单 业绩高增驱动价值重估","url":"https://stock-news.laohu8.com/highlight/detail?id=2595277564","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2595277564?lang=zh_cn&edition=full","pubTime":"2025-12-29 08:54","pubTimestamp":1766969651,"startTime":"0","endTime":"0","summary":"近日，上交所与深交所公告，将百奥赛图-B调入港股通股票名单，自2025年12月24日起生效。回顾市场历史，纳入港股通往往是上市公司迎来价值重估的重要契机。凭借稀缺的商业模式、深厚的技术护城河和业绩面近期的显著利好，此次纳入港股通，将有望成为推动百奥赛图投资价值被二次重估的关键催化剂。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386322.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02315","BK1161","688796","BK0216"],"gpt_icon":0},{"id":"1102493660","title":"一周港股牛熊榜 | AI材料与有色爆发！中铝国际暴涨20.6%、力勤资源暴涨18.6%、中伟新材大涨16%；因股份解禁，周六福暴跌24.9%、药捷安康暴跌20.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1102493660","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1102493660?lang=zh_cn&edition=full","pubTime":"2025-12-26 16:46","pubTimestamp":1766738819,"startTime":"0","endTime":"0","summary":"24日镍概念集体走高，力勤资源、中伟新材、新疆新鑫矿业均涨幅近 9%。12月23日，周六福在港交所公告，董事会注意到公司H股价格近期出现不寻常波动。根据数据，此次药捷安康共计5名股东发生解禁，累计解禁股数达977.4万股，占比约2.46%。23日跌超18%、24日继续跌5.8%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/549ed9c19f16d97443cb9ffadc6a6514"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02579","HSI","06821","02068","01952","02268","02245","02315","03939","02617","HSTECH","06168","HSCEI"],"gpt_icon":1},{"id":"2593471013","title":"智通港股解盘 | 晶圆涨价持续助推AI材料端 稀有资源镍矿集体走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2593471013","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593471013?lang=zh_cn&edition=full","pubTime":"2025-12-24 19:51","pubTimestamp":1766577112,"startTime":"0","endTime":"0","summary":"备案文件显示，关税税率将至少提前 30 天公布。据其分析称，AI 服务器等产品电源芯片的大量需求占用 BCD 产能，是此次涨价主要行业因素，“暂不清楚未来其他晶圆厂是否会跟进涨价”。各种 AI 相关材料都在涨价，据报道，三星电子、SK 海力士等存储供应商已上调明年 HBM3E 价格，涨幅接近 20%。数据显示，此次越疆共计 36 名股东发生解禁，累计解禁股数约 1.93 亿股。公司2025 年第三季度营收 4.47 亿元，经调整净利润 0.65 亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385589.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1614","BK1225","03858","00148","02245","BK1607","BK4588","09858","BK0216","01057","BK1514","01812","06166","01117","BK1170","BK4213","BK1149","02498","BK1144","BK1116","BK1610","BK1163","BK0132","03833","BK1190","SG9999014674.SGD","GDP","02432","BK1237","BK1551","BK1553","BK1587","688796","BK1183","BK1179","BK1240","BK1161","02315","BK1223","BK4585","VIS","02314","BK1526","02689","00826","BK0264","002703","BK1212","00981","02579"],"gpt_icon":1},{"id":"2593421364","title":"港股半日市窄幅震荡 半导体核电逆势走强","url":"https://stock-news.laohu8.com/highlight/detail?id=2593421364","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593421364?lang=zh_cn&edition=full","pubTime":"2025-12-24 13:36","pubTimestamp":1766554560,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　港股速报 | 港股半日市窄幅震荡 半导体核电逆势走强。　　12月24日，受假期影响，港股迎来半日市，上午收盘后即完成全天交易。市场整体呈现窄幅震荡格局，板块分化特征显著，半导体、核电等板块逆势走强，航空股则持续承压。　　板块表现呈现明显分化，科技相关及能源类板块成为今日市场核心亮点。半导体板块强势上扬，成为半日市领涨主线之一。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-24/doc-inhcwnvp4495205.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-24/doc-inhcwnvp4495205.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SOXX","BK4588","02302","02315","01811","688981","BK4585","HSI","SMH","02878","HSTECH","01164"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.bbctg.com.cn","stockEarnings":[{"period":"1week","weight":0.0334},{"period":"1month","weight":0.2295},{"period":"3month","weight":0.4314},{"period":"6month","weight":0.6974},{"period":"1year","weight":3.8123},{"period":"ytd","weight":0.017}],"compareEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":0.0271},{"period":"3month","weight":-0.0022},{"period":"6month","weight":0.0867},{"period":"1year","weight":0.3633},{"period":"ytd","weight":0.0235}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"百奥赛图（北京）医药科技股份有限公司是一家主要基于自主开发的基因编辑技术提供各类创新模式动物以及临床前阶段的医药研发服务的中国公司。该公司利用其自主开发的“RenMice”全人源抗体和T细胞受体（TCR）小鼠平台针对人体内潜在药物靶点进行规模化药物发现与开发。该公司主要业务包括创新模式动物销售、临床前药理药效评价服务及抗体开发。该公司还提供基因编辑服务。该公司在中国国内市场及海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.075218},{"month":2,"riseRate":0.666667,"avgChangeRate":0.052338},{"month":3,"riseRate":0.333333,"avgChangeRate":0.185414},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.066586},{"month":5,"riseRate":0.666667,"avgChangeRate":0.14952},{"month":6,"riseRate":0.333333,"avgChangeRate":0.011218},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.033427},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.055975},{"month":9,"riseRate":0.666667,"avgChangeRate":0.092895},{"month":10,"riseRate":0.25,"avgChangeRate":-0.096483},{"month":11,"riseRate":0.5,"avgChangeRate":0.009059},{"month":12,"riseRate":0.5,"avgChangeRate":0.137663}],"exchange":"SEHK","name":"百奥赛图-B","nameEN":"BIOCYTOGEN-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百奥赛图-B,02315,百奥赛图-B股票,百奥赛图-B股票老虎,百奥赛图-B股票老虎国际,百奥赛图-B行情,百奥赛图-B股票行情,百奥赛图-B股价,百奥赛图-B股市,百奥赛图-B股票价格,百奥赛图-B股票交易,百奥赛图-B股票购买,百奥赛图-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百奥赛图-B(02315)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百奥赛图-B(02315)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}